Article
LANCET  (2001)

Cautions over idiopathic aldosteronism [6]

Fraser, R; Lever A.F.; Brown J.J.; Robertson J.I.S.; Lim P.O.; McDonald T.M.; Fardella, C.; Mosso L.; Montero J.

Keywords: age, overexpression, antagonists, hypertension, plasma, blood, gene, susceptibility, histopathology, release, synthase, aldosterone, hyperaldosteronism, electrolyte, tumor, spironolactone, humans, potassium, human, agents, sodium, angiotensin, level, pathophysiology, agent, targeting, renin, adenoma, multivariate, cortex, drug, factor, antagonist, amiloride, primary, analysis, environmental, activity, genetic, code, statistical, epidemic, clinical, letter, adrenal, priority, journal, essential, note, antihypertensive, ii, feature, fludrocortisone, standing